Shares of Alkermes ALKS are higher on the session by 3.64%, trading at $17.53.
Overall call volume is now running at 7.27x the daily average, with 0% of all calls traded being purchases on the offer. 1,860 contracts have traded on the session so far.
Alkermes, Inc. is an integrated biotechnology company. The company is engaged in the business of developing, manufacturing and commercializing medicines for the treatment of prevalent, chronic diseases.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in